TO BE honest, as a venture capitalist I am a little bit bored with the simple “me-too” concepts companies have been presenting lately and the onslaught of press releases that hail new alliances between big pharma and small biotech companies. All of these deals have one thing in common: they entail enormous investments from the big company into the small company, revealing the continued dependence of the biotech companies on the larger corporate sponsors they serve.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.